Financial Year End | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 |
---|---|---|---|---|---|---|---|---|
Revenue | 294.48M | 327.89M | 387.18M | 329.65M | 306.50M | 276.98M | 244.73M | 211.14M |
Cost of Revenue | 95.16M | 97.17M | 101.07M | 107.85M | 98.92M | 82.96M | 68.53M | 60.57M |
Gross Profit | 199.31M | 230.72M | 286.11M | 221.79M | 207.57M | 194.02M | 176.19M | 150.57M |
Operating Expenses | 214.59M | 192.38M | 220.42M | 184.23M | 168.16M | 140.22M | 109.91M | 100.85M |
Selling, General & Admin | 85.41M | 73.75M | 95.66M | 82.78M | 62.58M | 50.43M | 47.39M | 40.95M |
Research & Development | 123.33M | 107.12M | 112.07M | 88.90M | 93.06M | 80.96M | 56.76M | 53.57M |
Other Operating Expenses | 1.11M | 11.52M | 12.69M | 12.54M | 12.52M | -54.00K | 5.76M | 6.33M |
Operating Income | -27.20M | 38.33M | 60.59M | 14.83M | 64.76M | 36.85M | 63.69M | 49.72M |
Other Expenses / Income | -10.81M | -237.08M | -12.32M | -40.97M | -50.33M | -17.00M | -483.00K | -2.46M |
Before Tax Income | -36.39M | -198.75M | 48.27M | -26.14M | 14.42M | 36.80M | 63.20M | 47.26M |
Income Tax Expenses | 19.86M | 112.08M | 2.38M | -5.51M | -87.66M | 30.92M | 15.93M | 12.32M |
Net Income | -56.25M | -310.83M | 45.89M | -20.63M | 102.08M | 5.88M | 47.28M | 34.94M |
Interest Expenses | 14.77M | 14.39M | 14.00M | 22.74M | N/A | N/A | N/A | N/A |
Basic Shares Outstanding | 40.22M | 39.19M | 37.75M | 36.43M | 36.40M | 36.39M | 36.39M | 36.39M |
Diluted Shares Outstanding | 40.22M | 39.19M | 39.29M | 36.43M | 36.40M | 36.39M | 36.39M | 36.39M |
EBITDA | 6.33M | 62.27M | 97.02M | 44.88M | 93.60M | 96.51M | 82.87M | 67.01M |
EBITDA Margin | 2.15% | 18.99% | 25.06% | 13.61% | 30.54% | 34.84% | 33.86% | 31.74% |
EBIT | -21.62M | -184.36M | 62.27M | -3.40M | 14.42M | 36.80M | 63.20M | 47.26M |
EBIT Margin | -7.34% | -56.23% | 16.08% | -1.03% | 4.71% | 13.29% | 25.83% | 22.38% |
Financial Year End | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 |